These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 32676810)

  • 21. Exploration of New and Potent Lead Molecules Against CAAX Prenyl Protease I of Leishmania donovani Through Pharmacophore Based Virtual Screening Approach.
    Prabhu SV; Tiwari K; Suryanarayanan V; Dubey VK; Singh SK
    Comb Chem High Throughput Screen; 2017; 20(3):255-271. PubMed ID: 28116998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wnt signalling and the actin cytoskeleton.
    Akiyama T; Kawasaki Y
    Oncogene; 2006 Dec; 25(57):7538-44. PubMed ID: 17143298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virtual screening of small molecules databases for discovery of novel PARP-1 inhibitors: combination of in silico and in vitro studies.
    Ekhteiari Salmas R; Unlu A; Bektaş M; Yurtsever M; Mestanoglu M; Durdagi S
    J Biomol Struct Dyn; 2017 Jul; 35(9):1899-1915. PubMed ID: 27315035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Shape-based virtual screening, docking, and molecular dynamics simulations to identify Mtb-ASADH inhibitors.
    Kumar R; Garg P; Bharatam PV
    J Biomol Struct Dyn; 2015; 33(5):1082-93. PubMed ID: 24875451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches.
    Jana S; Singh SK
    J Biomol Struct Dyn; 2019 Mar; 37(4):944-965. PubMed ID: 29475408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An integrated in silico screening strategy for identifying promising disruptors of p53-MDM2 interaction.
    Sirous H; Chemi G; Campiani G; Brogi S
    Comput Biol Chem; 2019 Dec; 83():107105. PubMed ID: 31473433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel tumor necrosis factor-α (TNF-α) inhibitors from small molecule library screening for their therapeutic activity profiles against rheumatoid arthritis using target-driven approaches and binary QSAR models.
    Zaka M; Abbasi BH; Durdagi S
    J Biomol Struct Dyn; 2019 Jun; 37(9):2464-2476. PubMed ID: 30047845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A neoepitope derived from a novel human germline APC gene mutation in familial adenomatous polyposis shows selective immunogenicity.
    Majumder S; Shah R; Elias J; Mistry Y; Coral K; Shah P; Maurya AK; Mittal B; D'Silva JK; Murugan S; Mahadevan L; Sathian R; Ramprasad VL; Chakraborty P; Gupta R; Chaudhuri A; Khanna-Gupta A
    PLoS One; 2018; 13(9):e0203845. PubMed ID: 30256815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3D Pharmacophore-Based Virtual Screening and Docking Approaches toward the Discovery of Novel HPPD Inhibitors.
    Fu Y; Sun YN; Yi KH; Li MQ; Cao HF; Li JZ; Ye F
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28598377
    [No Abstract]   [Full Text] [Related]  

  • 30. Structural insights on identification of potential lead compounds targeting WbpP in Vibrio vulnificus through structure-based approaches.
    Sasikala D; Jeyakanthan J; Srinivasan P
    J Recept Signal Transduct Res; 2016 Oct; 36(5):515-30. PubMed ID: 26795501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural Investigation of Vinca Domain Tubulin Binders by Pharmacophore, Atom based QSAR, Docking and Molecular Dynamics Simulations.
    Athar M; Lone MY; Khedkar VM; Radadiya A; Shah A; Jha PC
    Comb Chem High Throughput Screen; 2017; 20(8):682-695. PubMed ID: 28486912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of type I and type II inhibitors of c-Yes kinase using in silico and experimental techniques.
    Ramakrishnan C; Mary Thangakani A; Velmurugan D; Anantha Krishnan D; Sekijima M; Akiyama Y; Gromiha MM
    J Biomol Struct Dyn; 2018 May; 36(6):1566-1576. PubMed ID: 28589758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
    Iqbal S; Anantha Krishnan D; Gunasekaran K
    J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorylation and activation of the Rac1 and Cdc42 GEF Asef in A431 cells stimulated by EGF.
    Itoh RE; Kiyokawa E; Aoki K; Nishioka T; Akiyama T; Matsuda M
    J Cell Sci; 2008 Aug; 121(Pt 16):2635-42. PubMed ID: 18653540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel chemical scaffolds of the tumor marker AKR1B10 inhibitors discovered by 3D QSAR pharmacophore modeling.
    Kumar R; Son M; Bavi R; Lee Y; Park C; Arulalapperumal V; Cao GP; Kim HH; Suh JK; Kim YS; Kwon YJ; Lee KW
    Acta Pharmacol Sin; 2015 Aug; 36(8):998-1012. PubMed ID: 26051108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the NF-κB/IκBα complex via fragment-based E-Pharmacophore virtual screening and binary QSAR models.
    Kanan T; Kanan D; Erol I; Yazdi S; Stein M; Durdagi S
    J Mol Graph Model; 2019 Jan; 86():264-277. PubMed ID: 30415122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In silico identification of inhibitors targeting N-Terminal domain of human Replication Protein A.
    Çınaroğlu SS; Timuçin E
    J Mol Graph Model; 2019 Jan; 86():149-159. PubMed ID: 30366191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of novel natural compound inhibitors targeting estrogen receptor α by an integrated virtual screening strategy.
    Yu E; Xu Y; Shi Y; Yu Q; Liu J; Xu L
    J Mol Model; 2019 Aug; 25(9):278. PubMed ID: 31463793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In silico identification of irreversible cathepsin B inhibitors as anti- cancer agents: virtual screening, covalent docking analysis and molecular dynamics simulations.
    Sbongile M; Soliman ME
    Comb Chem High Throughput Screen; 2015; 18(4):399-410. PubMed ID: 25747438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and Synthesis of TASIN Analogues Specifically Targeting Colorectal Cancer Cell Lines with Mutant Adenomatous Polyposis Coli (APC).
    Wang W; Zhang L; Morlock L; Williams NS; Shay JW; De Brabander JK
    J Med Chem; 2019 May; 62(10):5217-5241. PubMed ID: 31070915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.